Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer's disease

Neurobiology of Aging

Volumn 22, Issue 3, 2001, Pages 417-426

  Ishunina, Tatjana A ^a,b   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Aging; Alzheimer's disease; Estrogen receptor and ; Nucleus basalis of Meynert; Sex difference

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEYNERT BASAL NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BASAL NUCLEUS OF MEYNERT; CELL NUCLEUS; CYTOPLASM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN; SEX CHARACTERISTICS;

EID: 0034990228     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00255-4     Document Type: Article

References (74)

1. Loss of neurons in the NBM in Alzheimer's disease, paralysis agitans, and Korsakoff's disease
2. Neuron loss in the nucleus basalis of Meynert in Creutzfeldt-Jacob-disease
3. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein e 4 allele
4. Localization of estrogen receptor beta-immunoreactivity in astrocytes of the adult rat brain
5. Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus
6. Cytoplasmic estrogen receptors in rat brain: Immunocytochemical evidence using three antibodies with distinct epitopes
7. Estrogen receptor immunoreactivity in rat brain: Rapid effects of estradiol injection
8. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease
9. Abnormalities of the nucleus basalis in Down's syndrome
10. Stability of neuronal number in the human nucleus basalis of Meynert with age
11. The nucleus basalis in Huntington's disease
12. Potential role of the estrogen receptor gene (ESR1) in anxiety
13. Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alchoholics
14. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging
15. Cells containing immunoreactive estrogen receptor-alpha in the human basal forebrain
16. Expression of estrogen receptor-β protein in rodent ovary
17. Neuron numbers and sizes in aging brain: Comparisons of human, monkey, and rodent data
18. Steroid hormone receptors: Intracellular distribution
19. Estrogen and basal forebrain cholinergic neurons: Implications for brain aging, and Alzheimer's disease-related cognitive decline
20. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male, and female rats
21. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain, and hippocampal formation of adult rats
22. Intracellular traffic of steroid hormone receptors
23. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
24. Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: Colocalization with cholinergic receptors
25. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease
26. Differential expression of estrogen receptor α and β immunoreactivity in the human supraoptic nucleus in relation to sex and ageing
27. Sex-, and age-related p75 neurotrophin receptor expression in the human supraoptic nucleus
28. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: Size changes in relation to age, and sex
29. Immunohistochemical analysis of the basal forebrain in Alzheimer's disease
30. Expression and neuropeptidergic characterization of estrogen receptors (ERα, and ERβ) throughout the rat brain: Anatomical evidence of distinct roles of each subtype
31. Ultrastructural analysis of estrogen receptor immunoreactive neurons in the medial preoptic area of female rat brain
32. The basal nucleus of Meynert revised: The nerve cell number decreases with age
33. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei, and projection areas of female rats
34. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease, and their relationship to ageing, and to the accumulation of lipofuscin pigment
35. Aging, Alzheimer's disease and the cholinergic system of the basal forebrain
36. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group under the auspices of Department of Health, and Human Service Task Force on Alzheimer's Disease
37. The effects of ovariectomy and estrogen replacement on trkA, and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat
38. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry, and cortical connections of the septal area, diagonal band nuclei, nucleus basalis/substantia innominata, and hypothalamus in the rhesus monkey
39. Estrogen receptor immunoreactivity within subregions of the rat forebrain: Neuronal distribution and association with perikarya containing choline acetyltransferase
40. Nerve qrowth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis
41. Galanin receptor plasticity within the nucleus basalis in early, and late Alzheimer's disease: An in vitro autoradiographic analysis
42. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease
43. Nerve growth factor receptor immunorectivity within the nucleus basalis (Ch4) in Parkinson's disease: Reduced cell numbers, and co-localization with cholinergic neurons
44. Posttraining intrahippocampal estradiol injections enhance spatial memory in male rats: Interaction with cholinergic systems
45. Differential ligand activation of estrogen receptors ERα, and ERβ at AP1 sites
46. Menopause and post-menopause
47. The functional organization of the basal forebrain cholinergic system in primates, and the role of this system in Alzheimer's disease
48. The Global Detelioration Scale for assessment of primary degenerative dementia
49. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent
50. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease
51. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus
52. P75 Neurotrophin receptor in the nucleus basalis of Meynert in relation to age, sex, and Alzheimer's disease
53. Co-localization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons, and their differential reduction in Alzheimer's disease
54. A cytoarchitectonic and histochemical study of nucleus basalis, and associated cell groups in the normal human brain
55. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
56. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
57. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system
58. Effects of estrogen replacement on choline acetyltransferase, and trkA mRNA expression in the basal forebrain of aged rats
59. Menopause and estrogen deficiency as a risk factor in dementing illness: Hypothesis on the biological basis
60. Monoaminergic, and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): Normal age-related changes, and the effect of heart disease, and Alzheimer's disease
61. τ and ubiquitin in the human hypothalamus in aging, and Alzheimer's disease
62. Reduced neuronal activity, and reactivation in Alzheimer's disease
63. Neuron loss in the basal nucleus of Meynert in progressive supranuclear palsy
64. Pick's disease (labor sclerosis), depletion of neurons in the nucleus basalis of Meynert
65. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia, and alcohol-associated dementia
66. Hormone replacement therapy and Alzheimer's disease
67. Cell loss and shrinkage in the nucleus basalis of Meynert complex in Alzheimer's disease
68. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. A controlled study
69. Postmenopausal estrogen replacement therapy, and risk of AD: A population-based study
70. Estrogen receptor polymorphism predicts the onset of natural, and surgical menopause
71. Rett syndrome: Neurobiological changes underlying specific symptoms
72. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides
73. Estrogen use, APOE, and cognitive decline; evidence of gene-environment interaction
74. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations